The Cheshire & Merseyside (C&M) Health & Care Partnership (HCP) Prevention Board met on Thursday 21 March and discussed the following items:

  1. New funding for prevention - The C&M Prevention Board has been successful in its bid for £685,000 of transformational funding to accelerate progress on their priorities. The priorities that will be covered are alcohol harm, antimicrobial resistance (AMR), high blood pressure and physical activity as well as establishing a new Prevention Pledge.  Co-chair Eileen O’Meara, HCP Clinical Lead for Prevention and Director of Public Health for Halton, thanked all those involved with developing the bid and the detailed plans behind it.
  2. Liver scanners trial - The alcohol harm work has also had an important boost in funding to provide a number of FibroScan machines which will be trialled in various hospital and community settings across C&M to detect liver disease. Following the pilot, the most successful way to deploy the scanners across C&M will be decided.
  3. Population health plan update - The C&M Population Health Plan was discussed and Chris McBrien, Public Health Registrar, gave an update on progress so far. It is expected that a workshop will be held to share the vision and outcomes.
  4. AMR progress - An update paper on AMR was submitted by Dr Sam Ghebrehewet, PHE North West, and following the successful funding from the Local Workforce Advisory Board (LWAB), job descriptions are being developed for the GPs, community microbiologists and medicines management staff that will work on AMR. A meeting has been held with the University of Liverpool to look at progressing the immersive digital training platform for medical students.
  5. Funding for suicide prevention - The Board heard that the C&M No More Suicide Partnership Board, via the Champs Collaborative, had been successful in gaining over £600,000 for suicide prevention from NHS England. There are several areas of work including a focus on self-harm, middle aged men, quality improvement with mental health trusts, primary care, workforce development and lived experience. The funding will utilised to accelerate progress in delivering the No More Suicide Strategy and action plan.
  6. Blood pressure update - Dr Mel Roche, Public Health Consultant, gave an update on the blood pressure programme in C&M and of the recent national focus on preventing CVD including the release of the CVD ambitions covering Atrial Fibrillation (AF), High Blood Pressure and Cholesterol.  C&M has just updated its guideline for those colleagues testing blood pressures in the community and new z cards for the public will also be soon available. Thanks were given to Mel and to Paul Sedgewick for his clinical sign off on the new guidelines. The BP quality improvement package has been successful and an event on 2 May will look at how it can be scaled up across general practices in C&M.
  7. Community pharmacy achieve BP target - Hassan Argomandkhah updated the Board on the work of the community pharmacies and blood pressure testing. The target of 3,000 BP checks for the existing BHF pilot has been exceeded and recruitment is underway for additional healthy living pharmacies to take part in the new BHF funded project. There will be an additional 120 healthy living pharmacies taking part in the next phase of the BHF project.   
  8. Sharing plans - Jon Develing, Co-chair of the Prevention Board, presented the risk register and it was agreed to strengthen communication and share plans with other programmes and places. Jon also informed the Board that the HCP CVD Board had also been successful in its bid for transformational funding and will be used for AF, cholesterol and stroke.
  9. Thanks - Dave Sweeney, Implementation Lead for the C&M HCP, thanked all members of the Board for their work and commented on the importance of the Prevention programme within the Health & Care Partnership.